The application of mass spectrometry in molecular dosimetry: Ethylene oxide as an example

Mass Spectrometry Reviews

Volumn 30, Issue 5, 2011, Pages 733-756

  Wu, Kuen Yuh ^a   Chiang, Su Yin ^b   Shih, Wei Chung ^a   Huang, Chih Chun Jean ^c   Chen, Ming Feng ^c   Swenberg, James A ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d IL   (United States)

Author keywords

DNA adduct; ethylene oxide; mass spectrometry; protein adduct

Indexed keywords

ACTIVE METABOLITES; ANIMAL TISSUE; CANCER RISK; COLLISION ENERGIES; DETECTION SENSITIVITY; DNA ADDUCTS; DNA BASIS; EARLY PREDICTION; EASE-OF-USE; EPIDEMIOLOGICAL STUDIES; ETHYLENE OXIDE; ETHYLENE OXIDES; HIGH-THROUGHPUT; LC/MS/MS; MOBILE PHASE; MOLECULAR DOSIMETRY; REACTIVE SPECIES; SAMPLE PREPARATION PROCEDURE; SENSITIVE METHOD; SENSITIVITY AND SPECIFICITY;

AMINO ACIDS; CARCINOGENS; DNA; DOSIMETERS; DOSIMETRY; ETHYLENE; MASS SPECTROMETRY; PROTEINS; TISSUE;

BIOMARKERS;

2-HYDROXYETHYLVALINE; AIR POLLUTANT; BIOLOGICAL MARKER; DNA ADDUCT; ETHYLENE OXIDE; GUANINE; N(7)-HYDROXYETHYLGUANINE; VALINE;

AIR POLLUTANT; ANALOGS AND DERIVATIVES; ANALYSIS; ANIMAL; BRAIN LEVEL; CHEMISTRY; DNA ADDUCT; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIVER; LYMPHOCYTE; MASS FRAGMENTOGRAPHY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SPLEEN; TANDEM MASS SPECTROMETRY;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; DNA ADDUCTS; ETHYLENE OXIDE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GUANINE; HUMANS; LIVER; LYMPHOCYTES; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPLEEN; TANDEM MASS SPECTROMETRY; VALINE;

EID: 80052186196     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.20299     Document Type: Review

References (170)

1. Abdel-Baky S, Giese RW,. 1991. Gas chromatography/electron capture negative ion mass spectrometry at the zeptomole level. Anal Chem 63: 2986-2989.
2. Ahn HS, Shin HS,. 2006. Determination of ethylene oxide-hemoglobin adduct by silylation and gas chromatography-electron impact-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 843: 202-208.
3. Airoldi L, Vineis P, Colombi A, Olgiati L, Dell'Osta C, Fanelli R, Manzi L, Veglia F, Autrup H, Dunning A, Garte S, Hainaut P, Hoek G, Krzyzanowski M, Malaveille C, Matullo G, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Peluso M, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Chirlaque MD, Quiros JR, Berglund G, Järvholm B, Hallmans G, Day NE, Allen N, Saracci R, Kaaks R, Riboli E,. 2005. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study. Cancer Epidemiol Biomarkers Prev 14: 2118-2124. (Pubitemid 41603255)
4. Allam K, Saha M, Giese RW,. 1990. Preparation of electrophoric derivatives of N7-(2-hydroxyethyl)guanine, an ethylene oxide DNA adduct. J Chromatogr 499: 571-578. (Pubitemid 20044265)
5. Andrews CL, Vouros P, Harsch A,. 1999. Analysis of DNA adducts using high-performance separation techniques coupled to electrospray ionization mass spectrometry. J Chromatogr A 856: 515-526. (Pubitemid 29436025)
6. Angerer J, Bader M, Krämer A,. 1998. Ambient and biochemical effect monitoring of workers exposed to ethylene oxide. Int Arch Occup Environ Health 71: 14-18. (Pubitemid 28130005)
7. Apruzzese WA, Vouros P,. 1998. Analysis of DNA adducts by capillary methods coupled to mass spectrometry: A perspective. J Chromatogr A 794: 97-108. (Pubitemid 28083604)
8. Badghisi H, Liebler DC,. 2002. Sequence mapping of epoxide adducts in human hemoglobin with LC-tandem MS and the SALSA algorithm. Chem Res Toxicol 15: 799-805. (Pubitemid 34663620)
9. Bailey E, Farmer PB, Shuker DE,. 1987. Estimation of exposure to alkylating carcinogens by the GC-MS determination of adducts to hemoglobin and nucleic acid bases in urine. Arch Toxicol 60: 187-191. (Pubitemid 17081715)
10. Baird WM, Mahadevan B,. 2004. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention. Mutat Res 547: 1-4. (Pubitemid 38315066)
11. Ball L, Jones A, Boogaard P, Will W, Aston P,. 2004. Development of a competitive immunoassay for the determination of N-(2-hydroxyethyl)valine adducts in human haemoglobin and its application in biological monitoring. Biomarkers 9: 407-417. (Pubitemid 40403125)
12. Bartsch H, Caporaso N, Coda M, Kadlubar F, Malaveille C, Skipper P, Talaska G, Tannenbaum SR, Vineis P,. 1990. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 82: 1826-1831.
13. Bartsch H, Rojas M, Nair U, Nair J, Alexandrov K,. 1999. Genetic cancer susceptibility and DNA adducts: Studies in smokers, tobacco chewers, and coke oven workers. Cancer Detect Prev 23: 445-453. (Pubitemid 29536875)
14. Bastlová T, Andersson B, Lambert B, Kolman A,. 1993. Molecular analysis of ethylene oxide-induced mutations at hprt locus in human diploid fibroblasts. Mutat Res 287: 283-292. (Pubitemid 23174196)
15. Beyerbach A, Rothman N, Bhatnagar VK, Kashyap R, Sabbioni G,. 2006. Hemoglobin adducts in workers exposed to benzidine and azo dyes. Toxicol Appl Pharmacol 213: 198-206.
16. Bhanot OS, Singh US, Solomon JJ,. 1994. The role of 3- hydroxyethyldeoxyuridine in mutagenesis by ethylene oxide. J Biol Chem 269: 30056-30064. (Pubitemid 24365178)
17. Bodell WJ, Giannini DD, Hassenbush S, Levin VA,. 2001. Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors. Neuro-Oncology 3: 241-245. (Pubitemid 33674144)
18. Bolt HM, Leutbecher M, Golka K,. 1997. A note on the physiological background of the ethylene oxide adduct 7-(2-hydroxyethyl)guanine in DNA from human blood. Arch Toxicol 71: 719-721. (Pubitemid 27427521)
19. Bono R, Vincenti M, Meineri V, Pignata C, Saglia U, Giachino O, Scursatone E,. 1999. Formation of N-(2-hydroxyethyl)valine due to exposure to ethylene oxide via tobacco smoke: A risk factor for onset of cancer. Environ Res 81: 62-71. (Pubitemid 29297695)
20. Bono R, Vincenti M, Saglia U, Pignata C, Russo R, Gilli G,. 2002. Tobacco smoke and formation of N-(2-hydroxyethyl)valine in human hemoglobin. Arch Environ Health 57: 416-421. (Pubitemid 36278183)
21. Bono R, Vincenti M, Schiliro T, Traversi D, Pignata C, Scursatone E, Dotti G, Gilli G,. 2005. Cotinine and N-(2-hydroxyethyl)valine as markers of passive exposure to tobacco smoke in children. J Expo Anal Environ Epidemiol 15: 66-73. (Pubitemid 40170985)
22. Boogaard PJ,. 2002. Use of haemoglobin adducts in exposure monitoring and risk assessment. J Chromatogr B Anal Technol Biomed Life Sci 778: 309-322.
23. Boogaard PJ, Rocchi PS, van Sittert NJ,. 1999. Biomonitoring of exposure to ethylene oxide and propylene oxide by determination of hemoglobin adducts: Correlations between airborne exposure and adduct levels. Int Arch Occup Environ Health 72: 142-150. (Pubitemid 29251198)
24. Brugnone F, Perbellini L, Faccini G, Pasini F,. 1986. Ethylene oxide exposure: Biological monitoring by analysis of alveolar air and blood. Int Arch Occup Environ Health 58: 105-112. (Pubitemid 16097037)
25. Calleman CJ, Ehrenberg L, Jansson B, Osterman-Golkar S, Segerbäck D, Svensson K, Wachtmeister CA,. 1978. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide. J Environ Pathol Toxicol 2: 427-442. (Pubitemid 9246960)
26. Chen YL, Wang CJ, Wu KY,. 2005. Method development for analysis of urinary N7-(benzo[a]pyrene-6-yl)guanine by using two-step solid-phase extraction and liquid chromatography tandem mass spectrometry. Rapid Commun Mass Spectrom 19: 893-898.
27. Chevolleau S, Jacques C, Canlet C, Tulliez J, Debrauwer L,. 2007. Analysis of hemoglobin adducts of acrylamide and glycidamide by liquid chromatography-electrospray ionization tandem mass spectrometry, as exposure biomarkers in French population. J Chromatogr A 1167: 125-134. (Pubitemid 47422257)
28. Chiarelli MP, Lay JO, Jr., 1992. Mass spectrometry for the analysis of carcinogen-DNA adducts. Mass Spectrom Rev 11: 447-493.
29. Chien YC, Liu HH, Lin YC, Su PC, Li LH, Chang CP, Tang DT, Chen CY,. 2007. Ethylene oxide sterilization in the medical-supply manufacturing industry: Assessment and control of worker exposure. J Biomed Mater Res Part B: Appl Biomater 83B: 527-537.
30. Clemens MR, Einsele H, Frank H, Remmer H, Waller HD,. 1983. Volatile hydrocarbons from hydrogen peroxide-induced lipid peroxidation of erythrocytes and their cell compounds. Biochem Pharmacol 32: 3877-3878. (Pubitemid 14212224)
31. Cloutier JF, Castonguay A, O'Connor TR, Drouin R,. 2001. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines. J Mol Biol 306: 169-188. (Pubitemid 33032872)
32. Coggon D, Harris EC, Poole J, Palmer KT,. 2004. Mortality of workers exposed to ethylene oxide: Extended follow up of a British cohort. Occup Environ Med 61: 358-362. (Pubitemid 39214552)
33. Cushnir JR, Naylor S, Lamb JH, Farmer PB,. 1993. Tandem mass spectrometric approaches for the analysis of alkylguanines in human urine. Org Mass Spectrom 28: 552-558.
34. Doerge DR, Churchwell MI, Beland FA,. 2002. Analysis of DNA adducts from chemical carcinogens and lipid peroxidation using liquid chromatography and electrospray mass spectrometry. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 20: 1-20. (Pubitemid 34650712)
35. Dunkelberg H,. 1982. Carcinogenicity of ethylene oxide and 1,2-propylene oxide upon intragastric administration to rats. Br J Cancer 46: 924-933. (Pubitemid 13177700)
36. Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I,. 1974. Evaluation of generic risk of alkylating agents, tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24: 83-103.
37. 32P-postlabeling and high resolution GC/MS in quantifying N7-(2-hydroxyethyl)guanine adducts. Chem Res Toxicol 12: 979-984. (Pubitemid 29498373)
38. 6- alkylguanine-DNA alkyltransferase. Proc Natl Acad Sci USA 86: 8620-8624. (Pubitemid 20010275)
39. Farmer PB,. 1994. Carcinogen adducts: Use on diagnosis and risk assessment. Clin Chem 40: 1438-1443. (Pubitemid 24217663)
40. Farmer PB,. 1999. Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents. Mutat Res 428: 69-81. (Pubitemid 29389678)
41. Farmer PB,. 2004. Exposure biomarkers for the study of toxicological impact on carcinogenic processes. IARC Sci Publ 157: 71-90.
42. Farmer PB, Bailey E, Gorf SM, Törnqvist M, Osterman-Golkar S, Kautiainen A, Lewis-Enright DP,. 1986. Monitoring human exposure to ethylene oxide by the determination of haemoglobin adducts using gas chromatography-mass spectrometry. Carcinogenesis 7: 637-640. (Pubitemid 17135429)
43. Farmer PB, Bailey E, Naylor S, Anderson D, Brooks A, Cushnir J, Lamb JH, Sepai O, Tang YS,. 1993. Identification of endogenous electrophiles by means of mass spectrometric determination of protein and DNA adducts. Environ Health Perspect 99: 19-24. (Pubitemid 23174444)
44. Farmer PB, Brown K, Tompkins E, Emms VL, Jones DJ, Singh R, Phillips DH,. 2005. DNA adducts: Mass spectrometry methods and future prospects. Toxicol Appl Pharmacol 207 (2 Suppl): 293-301.
45. Farmer PB, Singh R,. 2008. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: The increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens. Mutat Res 659: 68-76.
46. Fedtke N, Swenberg JA,. 1991. Quantitative analysis of DNA adducts: The potential for mass spectrometric techniques. In:, Groopman JD, Skipper PL, editors. Molecular dosimetry and human cancer: Analytical epidemiological, and social considerations. Boca Raton, FL: CRC Press. pp 171-188.
47. Fennell TR, MacNeela JP, Morris RW, Watson M, Thompson CL, Bell DA,. 2000. Hemoglobin adducts from acrylonitrile and ethylene oxide in cigarette smokers: Effects of glutathione S-transferase T1-null and M1-null genotypes. Cancer Epidemiol Biomarkers Prev 9: 705-712. (Pubitemid 30482702)
48. Filser JG, Bolt HM,. 1983. Exhalation of ethylene oxide by rats on exposure to ethylene. Mutat Res 120: 57-60. (Pubitemid 13121310)
49. Filser JG, Denk B, Törnqvist M, Kessler W, Ehrenberg L,. 1992. Pharmacokinetics of ethylene in man: Body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Arch Toxicol 66: 157-163.
50. Föst U, Marczynski B, Kasemann R, Peter H,. 1989. Determination of 7-(2-hydroxyethyl)guanine with gas chromatography/mass spectrometry as a parameter for genotoxicity of ethylene oxide. Arch Toxicol 13 (Suppl): 250-253. (Pubitemid 19207664)
51. Gallo V, Khan A, Gonzales C, Phillips DH, Schoket B, Györffy E, Anna L, Kovács K, MÃller P, Loft S, Kyrtopoulos S, Matullo G, Vineis P,. 2008. Validation of biomarkers for the study of environmental carcinogens: A review. Biomarkers 13: 505-534. (Pubitemid 352044261)
52. Giese RW, Vouros P,. 1993. Method development toward the measurement of polyaromatic hydrocarbon-DNA adducts by mass spectrometry. Health Effects Institute Research Report No. 61.
53. Giese RW,. 1997. Detection of DNA adducts by electron capture mass spectrometry. Chem Res Toxicol 10: 255-270. (Pubitemid 27137136)
54. Giese RW,. 2000. Electron-capture mass spectrometry: Recent advances. J Chromatogr A 892: 329-346.
55. Gold B, Marky LM, Stone MP, Williams LD,. 2006. A review of the role of the sequence-dependent electrostatic landscape in DNA alkylation patterns. Chem Res Toxicol 19: 1402-1414. (Pubitemid 44863481)
56. Gresie-Brusin DF, Kielkowski D, Baker A, Channa K, Rees D,. 2007. Occupational exposure to ethylene oxide during pregnancy and association with adverse reproductive outcomes. Int Arch Occup Environ Health 80: 559-565. (Pubitemid 46711590)
57. Grevatt PC, Donahu JM, Bhanot OS,. 1991. The role of N3- ethyldeoxythymidine in mutagenesis and cytotoxicity by ethylating agents. J Biol Chem 266: 1269-1275. (Pubitemid 21907254)
58. Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, Montesano R, Wild CP,. 1992. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in the Gambia, West Africa. Cancer Epidemiol Biomarkers Prev 1: 221-227.
59. Halket JM,. 1994. Derivatives for gas chromatography-mass spectrometry. In:, Blau K, Halket JM, editors. Handbook of derivatives for chromatography. Chichester, UK: John Wily & Sons. pp 297-325.
60. Hallier JM, Langhof T, Dannappel D,. 1993. Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide, and dichloromethane in human blood: Influence on the induction of sister chromatin exchanges (SCEs) in lymphocytes. Arch Toxicol 67: 173-178. (Pubitemid 23104870)
61. Haufroid V, Merz B, Hofmann A, Tschopp A, Lison D, Hotz P,. 2007. Exposure to ethylene oxide in hospitals: Biological monitoring and influence of glutathione S-transferase and epoxide hydrolase polymorphisms. Cancer Epidemiol Biomarkers Prev 16: 796-802. (Pubitemid 46650584)
62. Hemminki K, Alhonen-Raatesalmi A, Koivisto P, Vodicka P,. 1990. Synthesis and stability of 2'-deoxyguanosine 3â-monophosphate adducts of dimethyl sulfate, ethylene oxide and styrene oxide. Chem Biol Interact 75: 281-292. (Pubitemid 20230195)
63. Hemminki K, Axelson O, Niemi ML, Ahlborg G,. 1983. Assessment of methods and results of reproductive occupational epidemiology: Spontaneous abortions and malformations in the offspring of working women. Am J Ind Med 4: 293-307. (Pubitemid 13135994)
64. Himmelstein MW, Boogaard PJ, Cadet J, Farmer PB, Kim JH, Martin EA, Persaud R, Shuker DE,. 2009. Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol 39: 679-694.
65. Honda A, Suzuki Y, Suzuki K,. 2008. Review of molecular modification techniques for improved detection of biomolecules by mass spectrometry. Anal Chim Acta 623: 1-10.
66. Huang CC, Shih WC, Wu CF, Chen MF, Chen YL, Lin YH, Wu KY,. 2008. Rapid and sensitive on-line liquid chromatographic/tandem mass spectrometric determination of an ethylene oxide-DNA adduct, N7-(2-hydroxyethyl)guanine, in urine of nonsmokers. Rapid Commun Mass Spectrom 22: 706-710.
67. Huber CG, Oberacher H,. 2001. Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. Mass Spectrom Rev 20: 310-343. (Pubitemid 34514981)
68. IARC monographs on the evaluation of carcinogenic risks to humans: Some industrial chemicals. 1994. International Agency for Research on Cancer, Vol. 60. Lyon, France: pp 73-159.
69. Kanaly RA, Hanaoka T, Sugimura H, Toda H, Matsui S, Matsuda T,. 2006. Development of the adductome approach to detect DNA damage in humans. Antioxid Redox Signal 8: 993-1001. (Pubitemid 44036516)
70. Kanaly RA, Matsui S, Hanaoka T, Matsuda T,. 2007. Application of the adductome approach to assess intertissue DNA damage variations in human lung and esophagus. Mutat Res 625: 83-93. (Pubitemid 350016107)
71. Kao CY, Giese RW,. 2005. Measurement of N7-(2â-hydroxyethyl)guanine in human DNA by gas chromatography electron capture mass spectrometry. Chem Res Toxicol 18: 70-75. (Pubitemid 40111094)
72. Kessler W, Remmer H,. 1990. Generation of volatile hydrocarbons from amino acids and proteins by an iron/ascorbate/GSH system. Biochem Pharmacol 39: 1347-1351. (Pubitemid 20119210)
73. Koc H, Swenberg JA,. 2002. Applications of mass spectrometry for quantitation of DNA adducts. J Chromatogr B 778: 323-343.
74. 32P-postlabelling of 2-hydroxyethylated, ethylated and methylated adducts of 2â-deoxyguanosine 3â-monophosphate. Carcinogenesis 11: 1389-1392. (Pubitemid 20245714)
75. Kumar R, Hemminki K,. 1996. Separation of 7-methyl- and 7-(2-hydroxyethyl)-guanine adducts in human DNA samples using a combination of TLC and HPLC. Carcinogenesis 17: 485-492. (Pubitemid 26085328)
76. 32P-postlabeling method for the detection of 7-alkylguanine adducts for by reaction of different 1,2-alkyl epoxide with DNA. Carcinogenesis 16: 483-489.
77. La DK, Swenberg JA,. 1996. DNA adducts: Biological markers of exposure and potential applications to risk assessment. Mutat Res 365: 129-146. (Pubitemid 26344743)
78. Leclercq L, Laurent C, De PE,. 1997. High-performance liquid chromatography/electrospray mass spectrometry for the analysis of modified bases in DNA: 7-(2-hydroxyethyl)guanine, the major ethylene oxide-DNA adduct. Anal Chem 69: 1952-1955.
79. Lee GSF, Blonsky KS, Van On DL, Savage EA, Morgan AR, von Borstel RC,. 1992. Base alternations in yeast induced by alkylation agents with differing Swain-Scott substrate constants. J Mol Biol 233: 617-626.
80. Li F, Segal A, Solomon JJ,. 1992. In vitro reaction of ethylene oxide with DNA and characterization of DNA adducts. Chem Biol Interact 83: 35-54.
81. Liao PC, Li CM, Hung CW, Chen SH,. 2001. Quantitative detection of N(7)-(2-hydroxyethyl)guanine adducts in DNA using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom 36: 336-343.
82. Liberman M, Mapson LW,. 1964. Genesis and biogenesis of ethylene. Nature 204: 343-345.
83. Lin JS, Chuang KT, Huang MS, Wei KM,. 2007. Emission of ethylene oxide frying of foods in soybean oil. Food Chem Toxicol 45: 568-574. (Pubitemid 46209458)
84. 6-(2-hydroxyethyl)-2â-deoxyguanosine in DNA of various tissue following a single dose of N-nitroso-N-(2-hydroxyethyl)urea: An immuno-slot-blot study. Carcinogenesis 9: 147-151.
85. Lynch DW, Lewis TR, Moorman WJ, Burg JR, Groth DH, Khan A, Ackerman LJ, Cockrell BY,. 1984. Carcinogenic and toxicological effects of inhaled ethylene oxide and propylene oxide in F344 rats. Toxicol Appl Pharmacol 76: 69-84. (Pubitemid 14019487)
86. Major J, Jakab MG, Tompa A,. 1996. Genotoxicological investigation of hospital nurses occupationally exposed to ethylene-oxide. Environ Mol Mutagen 27: 84-92.
87. Marsden DA, Jones DJ, Lamb JH, Tompkins EM, Farmer PB, Brown K,. 2007. Determination of endogenous and exogenously derived N7-(2-hydroxyethyl)guanine adducts in ethylene oxide-treated rats. Chem Res Toxicol 20: 290-299. (Pubitemid 46408866)
88. Mattes WB, Hartley JA, Kohn KW, Matheson DW,. 1988. GC-rich regions in genomes as targets for DNA alkylation. Carcinogenesis 9: 2065-2072.
89. Mendes GC, Brandao TR, Silva CL,. 2007. Ethylene oxide sterilization of medical devices: A review. Am J Infect Control 35: 574-581. (Pubitemid 350007834)
90. Müller M, Kramer A, Angerer J, Hallier E,. 1998. Ethylene oxide-protein adduct formation in humans: Influence of glutathione-S-transferase polymorphisms. Int Arch Occup Environ Health 71: 499-502. (Pubitemid 28479435)
91. NTP (National Toxicology Program). 1986. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ethylene Oxide (CAS No. 75-21-8) in B6C3F1 Mice (Inhalation Studies). NIH Publication No. 86-2582.
92. Osterman-Golkar S, Ehrenberg L, Segerbäck D, Hällstrom I,. 1976. Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor. Mutat Res 34: 1-10.
93. Osterman-Golkar S, Farmer PB, Segerbäck D, Bailey E, Calleman CJ, Svensson K, Ehrenberg L,. 1983. Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin. Teratog Carcinog Mutagen 3: 395-405. (Pubitemid 14200131)
94. Pavlov YI, Suslov VV, Shcherbakova PV, Kunkle TA, Ono A, Matsuda A, Schaaper RM,. 1996. Base analog N6-hydroxyaminopurine mutagenesis in Escherichia coli: Genetic control and molecular specificity. Mutat Res 357: 1-15. (Pubitemid 26343855)
95. Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, Turteltaub KW,. 2000. Methods of DNA adduct determination and their application to testing compounds for genotoxicity. Environ Mol Mutagen 35: 222-233. (Pubitemid 30196666)
96. 32P-postlabeling analysis of DNA adducts. Methods Mol Biol 291: 3-12.
97. Poirier MC, Santella RM, Weston A,. 2000. Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21: 353-359. (Pubitemid 30137920)
98. Preston RJ,. 1999. Cytogenetic effects of ethylene oxide, with an emphasis on population monitoring. Crit Rev Toxicol 29: 263-282. (Pubitemid 29262955)
99. Ranasinghe A, Scheller N, Wu KY, Upton PB, Swenberg JA,. 1998. Application of gas chromatography/electron capture negative chemical ionization high-resolution mass spectrometry for analysis of DNA and protein adducts. Chem Res Toxicol 11: 520-526. (Pubitemid 28242497)
100. 32P-postlabeling test for DNA damage. Proc Natl Acad Sci USA 78: 6162-6169.
101. Rappaport SM, Yeowell-O'Connell K,. 1999. Protein adducts as dosimeters of human exposure to styrene, styrene-7,8-oxide, and benzene. Toxicol Lett 108: 117-126. (Pubitemid 29460776)
102. Rowland AS, Baird DD, Shore DL, Darden B, Wilcox AJ,. 1996. Ethylene oxide exposure may increase the risk of spontaneous abortion, preterm birth, and postterm birth. Epidemiology 7: 363-368. (Pubitemid 26202181)
103. Rundle A,. 2006. Carcinogen-DNA adducts as a biomarker for cancer risk. Mutat Res 600: 23-36.
104. Rusyn I, Asakura S, Li Y, Kosyk O, Koc H, Nakamura J, Upton PB, Swenberg JA,. 2005. Effects of ethylene oxide and ethylene inhalation on DNA adducts, apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen, and liver. DNA Repair 4: 1099-1110. (Pubitemid 41316587)
105. 1 in vivo in rats. Carcinogenesis 8: 819-824. (Pubitemid 17127894)
106. Sagai M, Ichinose T,. 1980. Age-related changes in lipid peroxidation measured by ethane, propane, butane, and pentane in respired gas of rats. Life Sci 27: 731-738. (Pubitemid 11192176)
107. Saha M, Abushamaa A, Giese RW,. 1995. General method for determining ethylene oxide and related N7-guanine DNA adducts by gas chromatography-electron capture mass spectrometry. J Chromatogr A 712: 345-354.
108. Saha M, Giese RW,. 1993. High-performance liquid chromatography versus solid-phase extraction for post-derivatization cleanup prior to gas chromatography-electron-capture negative-ion mass spectrometry of N1,N3-bis-(pentafluorobenzyl)-N7-(2-[pentafluorobenzyloxy]ethyl)xanthine, a product derived from an ethylene oxide DNA adduct. J Chromatogr 629: 35-40. (Pubitemid 23026571)
109. Saha M, Kresbach GM, Giese RW, Annan RS, Vouros P,. 1989. Preparation and mass spectral characterization of pentafluorobenzyl derivatives of alkyl and hydroxyethyl-nucleobase DNA adducts. Biomed Environ Mass Spectrom 18: 958-972. (Pubitemid 19268411)
110. Schettgen T, Broding HC, Angerer J, Drexler H,. 2002. Hemoglobin adducts of ethylene oxide, propylene oxide, acrylonitrile and acrylamide-biomarkers in occupational and environmental medicine. Toxicol Lett 134: 65-70. (Pubitemid 35007287)
111. Segerbäck D,. 1983. Alkylation of DNA and hemoglobin in the mouse following exposure to ethene and ethene oxide. Chem Biol Interact 45: 139-151. (Pubitemid 13039217)
112. Segerbäck D,. 1990. Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea. Carcinogenesis 11: 307-312. (Pubitemid 20072169)
113. Seo KY, Jelinsky SA, Loechler EL,. 2000. Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens. Mutat Res 463: 215-246.
114. Shen J, Kessler W, Denk B, Filser JG,. 1989. Metabolism and endogenous production of ethylene in rat and man. Arch Toxicol 13 (Suppl): 237-239. (Pubitemid 19207660)
115. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC. Methods Mol Biol 314: 307-321.
116. Singh R, Farmer PB,. 2006. Liquid chromatography-electrospray ionization-mass spectrometry: The future of DNA adduct detection. Carcinogenesis 27: 178-196. (Pubitemid 43159870)
117. Sisk SS, Pluta LJ, Meyer KG, Wong BC, Recio L,. 1997. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure. Mutat Res 391: 153-164. (Pubitemid 27308697)
118. Skipper PL, Tannenbaum SR,. 1990. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11: 507-518. (Pubitemid 20137396)
119. Smyth WF, Brooks P,. 2004. A critical evaluation of high performance liquid chromatography-electrospray ionisation-mass spectrometry and capillary electrophoresis-electrospray-mass spectrometry for the detection and determination of small molecules of significance in clinical and forensic science. Electrophoresis 25: 1413-1446. (Pubitemid 38885803)
120. Snellings MW, Weil CS, Manonpot RR,. 1984. A two-year inhalation study of the carcinogenic potential of ethylene oxide in Fischer rats. Toxicol Appl Pharmacol 75: 105-117. (Pubitemid 14060479)
121. Snow ET, Singh J, Kooenig KL, Solomon JJ,. 1994. Propylene oxide mutagenesis at template cytosine residue. Environ Mol Mutagen 23: 274-280. (Pubitemid 24227884)
122. Sowers L, Steenland K, Greife A, Horung R, Hayes R, Nowlin S, Morawetz J, Ringenburg V, Elliot L, Halperin W,. 1989. Hydrolysis of N3-methyl-2- deoxycytidine: Model compound for reactivity of protonated cytosine residue in DNA. Mutat Res 215: 131-138. (Pubitemid 19262937)
123. Steenland K, Stayner L, Deddens J,. 2004. Mortality analyses in a cohort of 18,235 ethylene oxide exposed workers: Follow up extended from 1987 to 1998. Occup Environ Med 61: 2-7. (Pubitemid 38091075)
124. Strickland PT, Routledge MN, Dipple A,. 1993. Methodologies for measuring carcinogen adducts in humans. Cancer Epidemiol Biomarkers Prev 2: 607-619.
125. Sturla SJ,. 2007. DNA adduct profiles: Chemical approaches to addressing the biological impact of DNA damage from small molecules. Curr Opin Chem Biol 11: 293-299. (Pubitemid 46963078)
126. Swenberg JA,. 2004. Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies. IARC Sci Publ 157: 237-246.
127. Swenberg JA, Fryar-Tita E, Jeong YC, Boysen G, Starr T, Walker VE, Albertini RJ,. 2008. Biomarkers in toxicology and risk assessment: Informing critical dose-response relationships. Chem Res Toxicol 21: 253-265. (Pubitemid 351219722)
128. Swenberg JA, Ham A, Koc H, Morinello E, Ranasinghe A, Tretyakova N, Upton PB, Wu KY,. 2000. DNA adducts: Effects of low exposure to ethylene oxide, vinyl chloride and butadiene. Mutat Res 464: 77-86. (Pubitemid 30035292)
129. Swenberg JA, La DK, Scheller NA, Wu KY,. 1995. Dose-response relationships for carcinogens. Toxicol Lett 82-83: 751-756. (Pubitemid 26057531)
130. Tarun M, Rusling JF,. 2005. Measuring DNA nucleobase adducts using neutral hydrolysis and liquid chromatography-mass spectrometry. Crit Rev Eukaryot Gene Expr 15: 295-316.
131. Tates AD, Boogaard PJ, Darroudi F, Natarajan AT, Caubo ME, van Sittert NJ,. 1995. Biological effect monitoring in industrial workers following incidental exposure to high concentrations of ethylene oxide. Mutat Res 329: 63-77.
132. Tates AD, Grummt T, Törnqvist M, Farmer PB, van Dam FJ, van MH, Schoemaker HM, Osterman-Golkar S, Uebel C, Tang YS,. 1991. Biological and chemical monitoring of occupational exposure to ethylene oxide. Mutat Res 250: 483-497.
133. Tavares R, Ramos P, Palminha J, Bispo MA, Paz I, Bras A, Rueff J, Farmer PB, Bailey E,. 1994. Transplacental exposure to genotoxins. Evaluation in haemoglobin of hydroxyethylvaline adduct levels in smoking and non-smoking mothers and their newborns. Carcinogenesis 15: 1271-1274. (Pubitemid 24193898)
134. Thier R, Bolt HM,. 2000. Carcinogenicity and genotoxicity of ethylene oxide: New aspects and recent advances. Crit Rev Toxicol 30: 595-608.
135. Thomas LC, Weichmann W,. 1991. Quantitative measurement via co-elution and dual-isotope detection by gas chromatography-mass spectrometry. J Chromatogr 587: 256-262.
136. Tompkins EM, Jones DLJ, Lamb JH, Marsden DA, Farmer PB, Brown K,. 2008. Simultaneous detection of five different 2-hydroxyethyl-DNA adducts formed by ethylene oxide exposure, using a high-performance liquid chromatography/ electrospray ionization tandem mass spectrometry assay. Rapid Commun Mass Spectrom 22: 19-28.
137. Törnqvist M, Fred C, Haglund J, Helleberg B, Paulsson B, Rydberg P,. 2002. Protein adducts: Quantitative and qualitative aspects of their formation, analysis and application. J Chromatogr B 778: 279-308.
138. Törnqvist M, Gustafsson B, Kautiainen A, Harms-Ringdahl M, Granath F, Ehrenberg L,. 1989. Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethylene and ethylene oxide. Carcinogenesis 10: 39-41. (Pubitemid 19032080)
139. Törnqvist M, Kautiainen A, Gatz RN, Ehrenberg L,. 1988. Hemoglobin adducts in animals exposed to gasoline and diesel exhausts. 1. Alkenes. J Appl Toxicol 8: 159-170.
140. Törnqvist M, Mowrer J, Jensen S, Ehrenberg L,. 1986a. Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem 154: 255-266. (Pubitemid 16063368)
141. Törnqvist M, Osterman-Golkar S, Kautiainen A, Jensen S, Farmer PB, Ehrenberg L,. 1986b. Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin. Carcinogenesis 7: 1519-1521.
142. US EPA. 2005. Guidelines for Carcinogen Risk Assessment EPA/630/P-03/001F.
143. van Delft JH, van Weert EJ, van Winden MJ, Baan RA,. 1991. Determination of N7-(2-hydroxyethyl)guanine by HPLC with electrochemical detection. Chem Biol Interact 80: 281-289.
144. van Delft JH, van Winden MJ, Luiten-Schuite A, Ribeiro LR, Baan RA,. 1994. Comparison of various immunochemical assays for the detection of ethylene oxide-DNA adducts with monoclonal antibodies against imidazole ring-opened N7-(2-hydroxyethyl)guanosine: Application in a biological monitoring study. Carcinogenesis 15: 1867-1873.
145. van Sittert NJ, Beulink GD, van Vliet EW, van der WH,. 1993. Monitoring
146. van Sittert NJ, Boogaard PJ, Natarajan AT, Tates AD, Ehrenberg LG, Törnqvist MA,. 2000. Formation of DNA adducts and induction of mutagenic effects in rats following 4 weeks inhalation exposure to ethylene oxide as a basis for cancer risk assessment. Mutat Res 447: 27-48. (Pubitemid 30109312)
147. van Sittert NJ, de JG, Clare MG, Davies R, Dean BJ, Wren LJ, Wright AS,. 1985. Cytogenetic, immunological, and haematological effects in workers in an ethylene oxide manufacturing plant. Br J Ind Med 42: 19-26. (Pubitemid 15087712)
148. Walker VE, Fennell TR, Boucheron JA, Fedtke N, Ciroussel F, Swenberg JA,. 1990. Molecular adducts of ethylene oxide: A literature review and a time-course study on the formation of 7-(2-hydroxyethyl)guanine following exposures of rats by inhalation. Mutat Res 233: 151-164. (Pubitemid 20379152)
149. Walker VE, Fennell TR, Upton PB, MacNeela JP, Swenberg JA,. 1993. Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide. Environ Health Perspect 9: 11-17. (Pubitemid 23174443)
150. Walker VE, Fennell TR, Upton PB, Skopek TR, Prevost V, Shuker DE, Swenberg JA,. 1992a. Molecular dosimetry of ethylene oxide: Formation and persistence of 7-(2-hydroxyethyl)guanine in DNA following repeated exposures of rats and mice. Cancer Res 52: 4328-4334.
151. Walker VE, MacNeela JP, Swenberg JA, Turner MJ, Jr., Fennell TR,. 1992b. Molecular dosimetry of ethylene oxide: Formation and persistence of N-(2-hydroxyethyl)valine in hemoglobin following repeated exposures of rats and mice. Cancer Res 52: 4320-4327.
152. Walker VE, Wu KY, Upton PB, Ranasinghe A, Scheller N, Cho MH, Vergnes JS, Skopek TR, Swenberg JA,. 2000. Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide. Carcinogenesis 21: 1661-1669.
153. Walker VE, Skopek TR,. 1993. A mouse model for the study of in vivo mutation spectra: Sequence specificity of ethylene oxide at the hprt locus. Mutat Res 288: 151-162. (Pubitemid 23193135)
154. Watada AE,. 1986. Effects of ethylene on the quality of fruits and vegetables. Food Technol 40: 82-85.
155. Westerholm R, Egebäck KE,. 1994. Exhaust emissions from light- and heavy-duty vehicles: Chemical composition, impact of exhaust after treatment, and fuel parameters. Environ Health Perspect 102 (Suppl 4): 13-23. (Pubitemid 24336079)
156. Weston A,. 1993. Physical methods for the detection of carcinogen-DNA adducts in humans. Mutat Res 288: 19-29. (Pubitemid 23193123)
157. Wolfs P, Dutrieux M, Scailteur V, Haxhe J-J, Zumofen M, Lauwery R,. 1983. Monitoring of workers exposed to ethylene oxide in a plant distributing sterilizing gas and in units for sterilizing medical equipment. Arch Mal Prof 44: 321-328. (Pubitemid 16143612)
158. Wraith MJ, Watson WP, Eadsforth CV, van Sittert NJ, Törnqvist M, Wright AS,. 1988. An immunoassay for monitoring human exposure to ethylene oxide. IARC Sci Pub 89: 271-274.
159. Wu KY,. 1997. Molecular dosimetry of N7-(2-hydroxyethyl)guanine: Exposure assessment, mechanistic study, and potential for risk assessment. Doctoral dissertation submitted to University of North Carolina at Chapel Hill.
160. Wu KY, Chiang SY, Huang TH, Tseng YS, Chen YL, Kuo HW, Hsieh CL,. 2004. Formation of N-(2-hydroxyethyl)valine in human hemoglobin-effect of lifestyle factors. Mutat Res 559: 73-82.
161. Wu KY, Ranasinghe A, Upton PB, Walker VE, Swenberg JA,. 1999a. Molecular dosimetry of endogenous and ethylene oxide-induced N7-(2-hydroxyethyl) guanine formation in tissues of rodents. Carcinogenesis 20: 1787-1792. (Pubitemid 29410559)
162. Wu KY, Scheller N, Ranasinghe A, Yen TY, Sangaiah R, Giese R, Swenberg JA,. 1999b. A gas chromatography/electron capture/negative chemical ionization high-resolution mass spectrometry method for analysis of endogenous and exogenous N7-(2-hydroxyethyl)guanine in rodents and its potential for human biological monitoring. Chem Res Toxicol 12: 722-729. (Pubitemid 29398535)
163. 6-ethenoadenine in rat urine by immunoaffinity extraction combined with liquid chromatography/electrospray ionization mass spectrometry. Chem Res Toxicol 11: 810-815. (Pubitemid 28350731)
164. Yong LC, Schulte PA, Kao CY, Giese RW, Boeniger MF, Strauss GH, Petersen MR, Wiencke JK,. 2007. DNA adducts in granulocytes of hospital workers exposed to ethylene oxide. Am J Ind Med 50: 293-302. (Pubitemid 46608577)
165. Yong LC, Schulte PA, Wiencke JK, Boeniger MF, Connally LB, Walker JT, Whelan EA, Ward EM,. 2001. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: Effects of glutathione S-transferase T1 and M1 genotypes. Cancer Epidemiol Biomarkers Prev 10: 539-550. (Pubitemid 32701641)
166. Young TL, Habraken Y, Ludlum DB, Santella RM,. 1990. Development of monoclonal antibodies recognizing 7-(2-hydroxyethyl)guanine and imidazole ring-opened 7-(2-hydroxyethyl)guanine. Carcinogenesis 11: 1685-1689. (Pubitemid 20331431)
167. Yu MW, Lien JP, Liaw YF, Chen CJ,. 1996. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts. Cancer Epidemiol Biomarkers Prev 5: 613-619.
168. Zhao C, Hemminki K,. 2002. The in vivo levels of DNA alkylation products in human lymphocytes are not age dependent: An assay of 7-methyl- and 7-(2-hydroxyethyl)-guanine DNA adducts. Carcinogenesis 23: 307-310. (Pubitemid 34224007)
169. Zhao C, Tyndyk M, Eide I, Hemminki K,. 1999. Endogenous and background DNA adducts by methylating and 2-hydroxyethylating agents. Mutat Res 424: 117-125. (Pubitemid 29101613)
170. Zayas B, Stillwell SW, Wishnok JS, Trudel LJ, Skipper P, Yu MC, Tannenbaum SR, Wogan GN,. 2007. Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis 28: 342-349. (Pubitemid 46321849)